State of Louisiana v. Pfizer Inc. and Warner-Lambert Company, LLC
Our attorneys defended Pfizer and Warner-Lambert against claims brought by the State of Louisiana. The government alleged that Pfizer and Warner-Lambert delayed the introduction of generic versions of Neurontin® by bringing alleged “sham” litigation to enforce patents, causing the State Medicaid Agency to overpay for branded Neurontin®, allegedly in violation of Louisiana anti-monopoly and other laws. Our team filed exceptions (Louisiana’s form of a motion to dismiss). In an effort to avoid dismissal, the State moved to consolidate the case with other allegedly similar cases. The assigned judge indicated that he was inclined to grant Pfizer’s request for dismissal. After that motion was granted, the firm sought a writ in the Appellate Court to reverse the consolidation, which was granted. The matter was resolved by a settlement in which Pfizer will donate to certain state agencies a drug used to treat opiate overdoses.